Validation of Monte Carlo (131)I radiopharmaceutical dosimetry workflow using a 3D‐printed anthropomorphic head and neck phantom

por Adam, David P., Grudzinski, Joseph J., Bormett, Ian, Cox, Benjamin L., Marsh, Ian R., Bradshaw, Tyler J., Harari, Paul M., Bednarz, Bryan P.
Publicado 2022

Antitumor efficacy of (90)Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors

por Potluri, Hemanth K, Ferreira, Carolina A, Grudzinski, Joseph, Massey, Christopher, Aluicio-Sarduy, Eduardo, Engle, Jonathan W, Kwon, Ohyun, Marsh, Ian R, Bednarz, Bryan P, Hernandez, Reinier, Weichert, Jamey P, McNeel, Douglas G
Publicado 2022

Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting

por Magee, Kara, Marsh, Ian R., Turek, Michelle M., Grudzinski, Joseph, Aluicio-Sarduy, Eduardo, Engle, Jonathan W., Kurzman, Ilene D., Zuleger, Cindy L., Oseid, Elizabeth A., Jaskowiak, Christine, Albertini, Mark R., Esbona, Karla, Bednarz, Bryan, Sondel, Paul M., Weichert, Jamey P., Morris, Zachary S., Hernandez, Reinier, Vail, David M.
Publicado 2021

Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy

por Jagodinsky, Justin C., Jin, Won Jong, Bates, Amber M., Hernandez, Reinier, Grudzinski, Joseph J., Marsh, Ian R., Chakravarty, Ishan, Arthur, Ian S., Zangl, Luke M., Brown, Ryan J., Nystuen, Erin J., Emma, Sarah E., Kerr, Caroline, Carlson, Peter M., Sriramaneni, Raghava N., Engle, Jonathan W., Aluicio-Sarduy, Eduardo, Barnhart, Todd E., Le, Trang, Kim, KyungMann, Bednarz, Bryan P., Weichert, Jamey P., Patel, Ravi B., Morris, Zachary S.
Publicado 2021